(Hypertension. 1996;27:495-501.)
© 1996 American Heart Association, Inc.
Articles |
From the Department of Medicine, Center for Molecular Genetics and American Heart Association Bugher Foundation Center for Molecular Biology, University of California, San Diego, La Jolla.
Abstract Unraveling the pathogenesis of complex cardiovascular diseases, such as hypertension, requires the development of in vivo animal model systems. Although large-animal models have long served as the gold standard, recent advances in transgenic and gene-targeting approaches, mouse genetics, and microsurgical technology are initiating a revolution that has led to the unexpected coupling of in vivo molecular physiology with genetically engineered mice. This article discusses the design of strategies to study complex cardiovascular phenotypes in genetically modified mice, including both transgenic and gene-targeted animals. At this time, a number of strategies are used to address specific molecular or physiological questions, and examples are briefly highlighted. In addition, a number of potential problems in the generation and use of transgenic mice in the study of cardiovascular biology are presented.
Key Words: models, cardiovascular animals, transgenic mice, knockout gene targeting mice, inbred strains myocardium
This article has been cited by other articles:
![]() |
R. Fazan Jr., M. de Oliveira, V. J. Dias da Silva, L. F. Joaquim, N. Montano, A. Porta, M. W. Chapleau, and H. C. Salgado Frequency-dependent baroreflex modulation of blood pressure and heart rate variability in conscious mice Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1968 - H1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Just, J. Faulhaber, and H. Ehmke Autonomic cardiovascular control in conscious mice Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2214 - R2221. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Knowles and N. Maeda Genetic Modifiers of Atherosclerosis in Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2336 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Sugden Signaling in Myocardial Hypertrophy : Life After Calcineurin? Circ. Res., April 2, 1999; 84(6): 633 - 646. [Full Text] [PDF] |
||||
![]() |
L. Li, G. Chu, E. G. Kranias, and D. M. Bers Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1335 - H1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Mattson Long-term measurement of arterial blood pressure in conscious mice Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R564 - R570. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. James and J. Robbins Molecular remodeling of cardiac contractile function Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2105 - H2118. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |